title: Evaluating Effects of Hypomorphic Thoc1 Alleles on Embryonic Development in Rb1 Null Mice.
abstract: The Rb1 tumor suppressor protein is a molecular adaptor that physically links transcription factors like E2f with various proteins acting on DNA or RNA to repress gene expression. Loss of Rb1 liberates E2f to activate the expression of genes mediating resulting phenotypes. Most Rb1 binding proteins, including E2f, interact through carboxyl-terminal protein interaction domains, but genetic evidence suggests that an amino-terminal protein interaction domain is also important. One protein that binds Rb1 through the amino-terminal domain is encoded by Thoc1, a required component of the THO ribonucleoprotein complex important for RNA processing and transport. The physiological relevance of this interaction is unknown. Here we tested whether Thoc1 mediates effects of Rb1 loss on mouse embryonic development. We found that Thoc1 deficiency delays embryo death, and this delay correlates with reduced apoptosis in the brain. E2f protein levels are reduced in Rb1:Thoc1-deficient brain tissue. Expression of apoptotic regulatory genes regulated by E2f, like Apaf1 and Bak1, is also reduced. These observations suggest that Thoc1 is required to support increased expression of E2f and apoptotic regulatory genes that trigger apoptosis upon Rb1 loss. These findings implicate Rb1 in the regulation of the THO ribonucleoprotein complex.
authors.affiliation: Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, USA.
authors.forename: Meenalakshmi
authors.initials: M
authors.lastname: Chinnam
authors.affiliation: Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, USA.
authors.forename: Xiaoling
authors.initials: X
authors.lastname: Wang
authors.affiliation: Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, USA.
authors.forename: Xiaojing
authors.initials: X
authors.lastname: Zhang
authors.affiliation: Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, USA david.goodrich@roswellpark.org.
authors.forename: David W
authors.initials: DW
authors.lastname: Goodrich
mesh_terms: D000818:Animals; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins / Q000235:genetics; D001921:Brain / Q000196:embryology* / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism*; D050684:E2F Transcription Factors / Q000378:metabolism; D047108:Embryonic Development; D005260:Female; D018507:Gene Expression Regulation, Developmental; D051379:Mice; D018345:Mice, Knockout; D011247:Pregnancy; D016601:RNA-Binding Proteins / Q000378:metabolism*; D016160:Retinoblastoma Protein / Q000235:genetics*
chemical_list: D051017:Apoptosis Regulatory Proteins; D004268:DNA-Binding Proteins; D050684:E2F Transcription Factors; D016601:RNA-Binding Proteins; D016160:Retinoblastoma Protein; C511176:Thoc1 protein, mouse